Atea Pharmaceuticals
AVIR
$3.96
Share price
3.39%
Change (1 day)
18.92%
Change (1 year)
Categories
EPS for Atea Pharmaceuticals (AVIR)
EPS in 2023 (TTM): -$1.28
According to Atea Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.28. In 2022 the company made an earnings per share (EPS) of -$1.40 a decrease over its 2021 EPS that were of $1.46.
EPS history for Atea Pharmaceuticals from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.28 | -8.57% |
| 2022 | -$1.40 | -195.89% |
| 2021 | $1.46 | -645.91% |
| 2020 | -$0.27 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 70.31% | 🇺🇸 USA |